Evidence map›Paper›PMID 31671590›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Synergy of Chemo- and Photodynamic Therapies with C

Anna Grebinyk, Svitlana Prylutska, Oksana Chepurna, Sergii Grebinyk, Yuriy Prylutskyy, Uwe Ritter, Tymish Y Ohulchanskyy, Olga Matyshevska, Thomas Dandekar, Marcus Frohme

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Frontiers in bioengineering and biotechnology · 2023
    Article
  5. Article
  6. Protective Effect of Water-Soluble CInternational journal of molecular sciences · 2021
    Article
  7. Article
  8. Review
  9. Synthesis, Characterization, Cellular Uptake, andFrontiers in pharmacology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Anna GrebinykDivision Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany. grebinyk@th-wildau.de.ORCID 0000-0002-4651-7908
Svitlana PrylutskaTaras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, Ukraine. psvit_1977@ukr.net.
Oksana ChepurnaKey Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China. ok.chepurna@gmail.com.
Sergii GrebinykDivision Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany. sgrebinyk@th-wildau.de.
Yuriy PrylutskyyTaras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, Ukraine. prylut@ukr.net.
Uwe RitterInstitute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Straße 25 (Curiebau), 98693 Ilmenau, Germany. uwe.ritter@tu-ilmenau.de.
Tymish Y OhulchanskyyKey Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China. tyo@szu.edu.cn.ORCID 0000-0002-7051-6534
Olga MatyshevskaPalladin Institute of Biochemistry, NAS of Ukraine, Leontovicha Str. 9, 01030 Kyiv, Ukraine. matysh@yahoo.com.
Thomas DandekarDepartment of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany. dandekar@biozentrum.uni-wuerzburg.de.ORCID 0000-0003-1886-7625
Marcus FrohmeDivision Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany. mfrohme@th-wildau.de.ORCID 0000-0001-9063-2682
Shenzhen University · CNTaras Shevchenko National University of Kyiv · UATechnical University of Applied Sciences Wildau · DEUniversity of Würzburg · DEPalladin Institute of Biochemistry · UATechnische Universität Ilmenau · DE

Funding

Bundesministerium für Bildung und Forschung Remis-3R, FKZ 031L0129BDeutscher Akademischer Austauschdienst 57129429National Natural Science Foundation of China 61875135Shenzhen Basic Research Project JCYJ20170818090620324
6 · The paper itself

Abstract

A nanosized drug complex was explored to improve the efficiency of cancer chemotherapy, complementing it with nanodelivery and photodynamic therapy. For this, nanomolar amounts of a non-covalent nanocomplex of Doxorubicin (Dox) with carbon nanoparticle C

Indexed as

apoptosisC60 fullereneDoxorubicinleukemic cellsnanocomplexphotodynamic chemotherapysynergistic effect

Identifiers

PMID31671590
PMCPMC6915635
OpenAlexW2982387085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.